The treatment for COVID-19 has evolved rapidly since the start of the pandemic and now
consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir …

Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

Clinical evidence indicates that COVID‐19 is a multiorgan disease that significantly impacts
the cardiovascular system. However, little is known about the predictors of myocardial …

The ongoing COVID-19 pandemic caused by SARS-CoV-2 is associated with acute
respiratory distress syndrome (ARDS) and fatal pneumonia. Excessive inflammation caused …

Introduction The impact of different doses of dexamethasone on outcomes from acute
COVID-19 pneumonia is unknown. Methods We performed a systematic review and meta …

We have read with great interest the study by de Kirenga et al., about efficacy and safety of
fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 [1] …

We have read with great interest the study by Deng et al.,[1] about Real-world effectiveness
of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19. Previous …

Discuss the pathogenesis of ARDS and the rationale for corticosteroid treatment. Evaluate
the evidence for the use of corticosteroids in specific subgroups of adults with ARDS. Apply …